Skip to main content
Erschienen in: Critical Care 2/2011

01.04.2011 | Review

Iron deficiency in critically ill patients: highlighting the role of hepcidin

verfasst von: Nicholas Heming, Philippe Montravers, Sigismond Lasocki

Erschienen in: Critical Care | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Excerpt

Iron is a paradoxical element, essential for living organsms but also potentially toxic. Indeed, iron has the ability to readily accept and donate electrons, interconverting from soluble ferrous form (Fe2+) to the insoluble ferric form (Fe3+). This capacity allows iron to play a major role in oxygen transport (as the central part of hemoglobin) but also in electron transfer, nitrogen fixation or DNA synthesis, all essential reactions for living organisms. Indeed, iron deficiency is the main cause of anemia [1] as well as a cause of fatigue [2, 3] and decreased effort capacity [4, 5]. However, despite a high frequency of anemia among critically ill patients, with 60 to 66% being anemic at intensive care unit (ICU) admission [6, 7], to date little is known about iron deficiency and iron metabolism in critically ill patients [8]. The interaction between inflammation and iron metabolism interferes with the usual iron metabolism variables and renders this metabolism difficult to investigate [9, 10]. …
Literatur
1.
Zurück zum Zitat Clark SF: Iron deficiency anemia. Nutr Clin Pract 2008, 23: 128-141. 10.1177/0884533608314536CrossRefPubMed Clark SF: Iron deficiency anemia. Nutr Clin Pract 2008, 23: 128-141. 10.1177/0884533608314536CrossRefPubMed
2.
Zurück zum Zitat Patterson AJ, Brown WJ, Powers JR, Roberts DC: Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res 2000, 9: 491-497. 10.1023/A:1008978114650CrossRefPubMed Patterson AJ, Brown WJ, Powers JR, Roberts DC: Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res 2000, 9: 491-497. 10.1023/A:1008978114650CrossRefPubMed
3.
Zurück zum Zitat Schultz BM, Freedman ML: Iron deficiency in the elderly. Baillieres Clin Haematol 1987, 1: 291-313. 10.1016/S0950-3536(87)80004-5CrossRefPubMed Schultz BM, Freedman ML: Iron deficiency in the elderly. Baillieres Clin Haematol 1987, 1: 291-313. 10.1016/S0950-3536(87)80004-5CrossRefPubMed
4.
Zurück zum Zitat Zhu YI, Haas JD: Iron depletion without anemia and physical performance in young women. Am J Clin Nutr 1997, 66: 334-341.PubMed Zhu YI, Haas JD: Iron depletion without anemia and physical performance in young women. Am J Clin Nutr 1997, 66: 334-341.PubMed
5.
Zurück zum Zitat Zhu YI, Haas JD: Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. J Appl Physiol 1998, 84: 1768-1775.PubMed Zhu YI, Haas JD: Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. J Appl Physiol 1998, 84: 1768-1775.PubMed
6.
Zurück zum Zitat Vincent JL, Baron JF, Reinhart K, et al.: Anemia and blood transfusion in critically ill patients. JAMA 2002, 288: 1499-1507. 10.1001/jama.288.12.1499CrossRefPubMed Vincent JL, Baron JF, Reinhart K, et al.: Anemia and blood transfusion in critically ill patients. JAMA 2002, 288: 1499-1507. 10.1001/jama.288.12.1499CrossRefPubMed
7.
Zurück zum Zitat Corwin HL, Gettinger A, Pearl RG, et al.: The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32: 39-52. 10.1097/01.CCM.0000104112.34142.79CrossRefPubMed Corwin HL, Gettinger A, Pearl RG, et al.: The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32: 39-52. 10.1097/01.CCM.0000104112.34142.79CrossRefPubMed
8.
9.
Zurück zum Zitat Darveau M, Denault AY, Blais N, Notebaert E: Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 2004, 8: 356-362. 10.1186/cc2862PubMedCentralCrossRefPubMed Darveau M, Denault AY, Blais N, Notebaert E: Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 2004, 8: 356-362. 10.1186/cc2862PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Pieracci FM, Barie PS: Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006, 34: 1898-1905. 10.1097/01.CCM.0000220495.10510.C1CrossRefPubMed Pieracci FM, Barie PS: Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006, 34: 1898-1905. 10.1097/01.CCM.0000220495.10510.C1CrossRefPubMed
11.
Zurück zum Zitat Nicolas G, Chauvet C, Viatte L, et al.: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110: 1037-1044.PubMedCentralCrossRefPubMed Nicolas G, Chauvet C, Viatte L, et al.: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110: 1037-1044.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Hentze MW, Muckenthaler MU, Galy B, Camaschella C: Two to tango: regulation of Mammalian iron metabolism. Cell 2010, 142: 24-38. 10.1016/j.cell.2010.06.028CrossRefPubMed Hentze MW, Muckenthaler MU, Galy B, Camaschella C: Two to tango: regulation of Mammalian iron metabolism. Cell 2010, 142: 24-38. 10.1016/j.cell.2010.06.028CrossRefPubMed
13.
Zurück zum Zitat Nemeth E, Tuttle MS, Powelson J, et al.: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306: 2090-2093. 10.1126/science.1104742CrossRefPubMed Nemeth E, Tuttle MS, Powelson J, et al.: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306: 2090-2093. 10.1126/science.1104742CrossRefPubMed
14.
Zurück zum Zitat Nemeth E, Rivera S, Gabayan V, et al.: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113: 1271-1276.PubMedCentralCrossRefPubMed Nemeth E, Rivera S, Gabayan V, et al.: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004, 113: 1271-1276.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 2005, 352: 1011-1023. 10.1056/NEJMra041809CrossRefPubMed Weiss G, Goodnough LT: Anemia of chronic disease. N Engl J Med 2005, 352: 1011-1023. 10.1056/NEJMra041809CrossRefPubMed
17.
Zurück zum Zitat Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, Lopez-Otin C: Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 2009, 94: 849-849. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, Lopez-Otin C: Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 2009, 94: 849-849.
18.
Zurück zum Zitat Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S: Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108: 3730-3735. 10.1182/blood-2006-06-028787PubMedCentralCrossRefPubMed Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S: Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108: 3730-3735. 10.1182/blood-2006-06-028787PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Vokurka M, Krijt J, Sulc K, Necas E: Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006, 55: 667-674.PubMed Vokurka M, Krijt J, Sulc K, Necas E: Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006, 55: 667-674.PubMed
20.
Zurück zum Zitat Tanno T, Bhanu NV, Oneal PA, et al.: High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007, 13: 1096-1101. 10.1038/nm1629CrossRefPubMed Tanno T, Bhanu NV, Oneal PA, et al.: High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007, 13: 1096-1101. 10.1038/nm1629CrossRefPubMed
21.
Zurück zum Zitat Hill SR, Carless PA, Henry DA, et al.: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Dat Syst Rev 2002, CD002042. Hill SR, Carless PA, Henry DA, et al.: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Dat Syst Rev 2002, CD002042.
22.
Zurück zum Zitat Walsh TS, Lee RJ, Maciver CR, et al.: Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 2006, 32: 100-109. 10.1007/s00134-005-2855-2CrossRefPubMed Walsh TS, Lee RJ, Maciver CR, et al.: Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 2006, 32: 100-109. 10.1007/s00134-005-2855-2CrossRefPubMed
23.
Zurück zum Zitat Bateman AP, McArdle F, Walsh TS: Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009, 37: 1906-1912. 10.1097/CCM.0b013e3181a000cfCrossRefPubMed Bateman AP, McArdle F, Walsh TS: Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009, 37: 1906-1912. 10.1097/CCM.0b013e3181a000cfCrossRefPubMed
24.
Zurück zum Zitat Corwin HL, Krantz SB: Anemia of the critically ill: "acute" anemia of chronic disease. Crit Care Med 2000, 28: 3098-3099. 10.1097/00003246-200008000-00079CrossRefPubMed Corwin HL, Krantz SB: Anemia of the critically ill: "acute" anemia of chronic disease. Crit Care Med 2000, 28: 3098-3099. 10.1097/00003246-200008000-00079CrossRefPubMed
25.
Zurück zum Zitat van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28: 2773-2778. 10.1097/00003246-200008000-00015CrossRefPubMed van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28: 2773-2778. 10.1097/00003246-200008000-00015CrossRefPubMed
26.
Zurück zum Zitat von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999, 27: 2630-2639. 10.1097/00003246-199912000-00005CrossRefPubMed von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU: Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999, 27: 2630-2639. 10.1097/00003246-199912000-00005CrossRefPubMed
27.
Zurück zum Zitat Wisser D, van Ackern K, Knoll E, Wisser H, Bertsch T: Blood loss from laboratory tests. Clin Chem 2003, 49: 1651-1655. 10.1373/49.10.1651CrossRefPubMed Wisser D, van Ackern K, Knoll E, Wisser H, Bertsch T: Blood loss from laboratory tests. Clin Chem 2003, 49: 1651-1655. 10.1373/49.10.1651CrossRefPubMed
28.
Zurück zum Zitat Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA 1997, 277: 973-976. 10.1001/jama.277.12.973CrossRefPubMed Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA 1997, 277: 973-976. 10.1001/jama.277.12.973CrossRefPubMed
29.
Zurück zum Zitat Smieja MJ, Cook DJ, Hunt DL, Ali MA, Guyatt GH: Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. CMAJ 1996, 155: 691-696.PubMedCentralPubMed Smieja MJ, Cook DJ, Hunt DL, Ali MA, Guyatt GH: Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. CMAJ 1996, 155: 691-696.PubMedCentralPubMed
30.
Zurück zum Zitat Jankowska EA, Rozentryt P, Witkowska A, et al.: Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010, 31: 1872-1880. 10.1093/eurheartj/ehq158CrossRefPubMed Jankowska EA, Rozentryt P, Witkowska A, et al.: Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010, 31: 1872-1880. 10.1093/eurheartj/ehq158CrossRefPubMed
31.
Zurück zum Zitat Bellamy MC, Gedney JA: Unrecognised iron deficiency in critical illness. Lancet 1998, 352: 1903. 10.1016/S0140-6736(98)00088-9CrossRefPubMed Bellamy MC, Gedney JA: Unrecognised iron deficiency in critical illness. Lancet 1998, 352: 1903. 10.1016/S0140-6736(98)00088-9CrossRefPubMed
32.
Zurück zum Zitat Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A: Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology 2010, 112: 1211-1215. 10.1097/ALN.0b013e3181d74f87CrossRefPubMed Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A: Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology 2010, 112: 1211-1215. 10.1097/ALN.0b013e3181d74f87CrossRefPubMed
33.
Zurück zum Zitat Huang H, Constante M, Layoun A, Santos MM: Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009, 113: 3593-3599. 10.1182/blood-2008-08-173641PubMedCentralCrossRefPubMed Huang H, Constante M, Layoun A, Santos MM: Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009, 113: 3593-3599. 10.1182/blood-2008-08-173641PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Lasocki S, Millot S, Andrieu V, et al.: Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008, 36: 2388-2394. 10.1097/CCM.0b013e31818103b9CrossRefPubMed Lasocki S, Millot S, Andrieu V, et al.: Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008, 36: 2388-2394. 10.1097/CCM.0b013e31818103b9CrossRefPubMed
35.
Zurück zum Zitat Theurl I, Aigner E, Theurl M, et al.: Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009, 113: 5277-5286. 10.1182/blood-2008-12-195651CrossRefPubMed Theurl I, Aigner E, Theurl M, et al.: Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009, 113: 5277-5286. 10.1182/blood-2008-12-195651CrossRefPubMed
36.
Zurück zum Zitat Kroot JJ, Kemna EH, Bansal SS, et al.: Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009, 94: 1748-1752. 10.3324/haematol.2009.010322PubMedCentralCrossRefPubMed Kroot JJ, Kemna EH, Bansal SS, et al.: Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009, 94: 1748-1752. 10.3324/haematol.2009.010322PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM: Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med, in press. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM: Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med, in press.
38.
Zurück zum Zitat Lasocki S, Baron G, Driss F, et al.: Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 2010, 36: 1044-1048. 10.1007/s00134-010-1794-8CrossRefPubMed Lasocki S, Baron G, Driss F, et al.: Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 2010, 36: 1044-1048. 10.1007/s00134-010-1794-8CrossRefPubMed
39.
Zurück zum Zitat Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA: Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ 2007, 177: 725-734.PubMedCentralCrossRefPubMed Zarychanski R, Turgeon AF, McIntyre L, Fergusson DA: Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ 2007, 177: 725-734.PubMedCentralCrossRefPubMed
40.
Zurück zum Zitat Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD: Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003, 77: 441-448.PubMed Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD: Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003, 77: 441-448.PubMed
41.
Zurück zum Zitat Anker SD, Comin Colet J, Filippatos G, et al.: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361: 2436-2448. 10.1056/NEJMoa0908355CrossRefPubMed Anker SD, Comin Colet J, Filippatos G, et al.: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361: 2436-2448. 10.1056/NEJMoa0908355CrossRefPubMed
42.
Zurück zum Zitat Javadi P, Buchman TG, Stromberg PE, et al.: High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med 2004, 32: 1178-1185. 10.1097/01.CCM.0000124878.02614.4CCrossRefPubMed Javadi P, Buchman TG, Stromberg PE, et al.: High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med 2004, 32: 1178-1185. 10.1097/01.CCM.0000124878.02614.4CCrossRefPubMed
43.
Zurück zum Zitat Driss F, Vrtovsnik F, Katsahian S, et al.: Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron Clin Pract 2005, 99: c63-c67. 10.1159/000083208CrossRefPubMed Driss F, Vrtovsnik F, Katsahian S, et al.: Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron Clin Pract 2005, 99: c63-c67. 10.1159/000083208CrossRefPubMed
44.
Zurück zum Zitat Marx JJ: Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002, 15: 411-426.CrossRefPubMed Marx JJ: Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002, 15: 411-426.CrossRefPubMed
45.
Zurück zum Zitat Hoen B, Paul-Dauphin A, Kessler M: Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 2002, 57: 457-461.CrossRefPubMed Hoen B, Paul-Dauphin A, Kessler M: Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 2002, 57: 457-461.CrossRefPubMed
46.
Zurück zum Zitat Dallman PR: Iron deficiency and the immune response. Am J Clin Nutr 1987, 46: 329-334.PubMed Dallman PR: Iron deficiency and the immune response. Am J Clin Nutr 1987, 46: 329-334.PubMed
47.
Zurück zum Zitat Auerbach M, Ballard H, Glaspy J: Clinical update: intravenous iron for anaemia. Lancet 2007, 369: 1502-1504. 10.1016/S0140-6736(07)60689-8CrossRefPubMed Auerbach M, Ballard H, Glaspy J: Clinical update: intravenous iron for anaemia. Lancet 2007, 369: 1502-1504. 10.1016/S0140-6736(07)60689-8CrossRefPubMed
48.
Zurück zum Zitat Notebaert E, Chauny JM, Albert M, Fortier S, Leblanc N, Williamson DR: Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 2007, 47: 1905-1918. 10.1111/j.1537-2995.2007.01415.xCrossRefPubMed Notebaert E, Chauny JM, Albert M, Fortier S, Leblanc N, Williamson DR: Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 2007, 47: 1905-1918. 10.1111/j.1537-2995.2007.01415.xCrossRefPubMed
49.
Zurück zum Zitat Pieracci FM, Henderson P, Rodney JR, et al.: Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 2009, 10: 9-19. 10.1089/sur.2008.043CrossRef Pieracci FM, Henderson P, Rodney JR, et al.: Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 2009, 10: 9-19. 10.1089/sur.2008.043CrossRef
Metadaten
Titel
Iron deficiency in critically ill patients: highlighting the role of hepcidin
verfasst von
Nicholas Heming
Philippe Montravers
Sigismond Lasocki
Publikationsdatum
01.04.2011
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 2/2011
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9992

Weitere Artikel der Ausgabe 2/2011

Critical Care 2/2011 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.